Meg Tirrell
Meg Tirrell is a CNN Medical Correspondent who specializes in health and wellness reporting. She is known for her insightful coverage of medical research and public health issues, including her discussions on the impact of ultraprocessed foods on dietary habits and health outcomes. Tirrell often engages with experts in the field to elucidate complex health topics for a general audience.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 6.00 | 0.05% | +0% | 331,002,651 | 174,395 | $21,000,000 | 11,064$ |
| Totals | 1 | 331,002,651 | 174,395 | $21,000,000 | 11,064$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Meg Tirrell explains what the Cyclospora false positive could mean for consumers.
6
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
8
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
7
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
8
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
8
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
7
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
6
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
8
United States:
Meg Tirrell reports on the FDA approving a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
7
United States:
CNN's Meg Tirrell reports on the FDA's approval of a daily pill version of Novo Nordisk's weight-loss drug Wegovy.
6